https://www.bioworld.com/rss en-us http://www.bioworld.com/articles/730618 Fri, 24 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730618-anaptysbios-spinout-first-tracks-hits-the-slopes Drug R&D concept image. http://www.bioworld.com/articles/730569 Wed, 22 Apr 2026 09:00:00 -0400 https://www.bioworld.com/articles/730569-jiangsu-vcare-pharmatech-identifies-new-il-17a-inhibitors BioWorld. Remedy is taking a secretome-based approach to treat lung disorders, having moved its lead asset, RC-0315, into a first-in-human clinical trial for idiopathic pulmonary fibrosis (IPF) in January. ]]> http://www.bioworld.com/articles/730576 Tue, 21 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730576-remedy-pushes-cell-free-secretome-therapy-for-ipf-into-phase-i Ayele Dilion Mashiah, CEO, Remedy Ayelet Dilion Mashiah, CEO, Remedy Cell Ltd. N-formyl peptide receptor 2 (FPR2; FPRL1; LXA4) agonists potentially useful for the treatment of chronic inflammation.]]> http://www.bioworld.com/articles/730462 Fri, 17 Apr 2026 09:00:00 -0400 https://www.bioworld.com/articles/730462-resother-pharma-synthesizes-new-fpr2-agonists a]pyrimidine derivatives acting as adenosine A3 receptor antagonists potentially useful for the treatment of ulcerative colitis, atopic dermatitis, glaucoma, asthma, liver fibrosis, renal disorders, hearing loss and glioblastoma, among others.]]> http://www.bioworld.com/articles/730438 Thu, 16 Apr 2026 09:00:00 -0400 https://www.bioworld.com/articles/730438-perha-pharmaceuticals-identifies-new-adenosine-a3-receptor-antagonists BioWorld. Remedy is taking a secretome-based approach to treat lung disorders, having moved its lead asset, RC-0315, into a first-in-human clinical trial for idiopathic pulmonary fibrosis (IPF) in January. Secretomes refer to the collection of bioactive molecules secreted by cells in the extracellular space, including proteins, enzymes, growth factors and extracellular vesicles such as exosomes.]]> http://www.bioworld.com/articles/730310 Wed, 15 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730310-remedy-pushes-cell-free-secretome-therapy-for-ipf-into-phase-i Ayele Dilion Mashiah, CEO, Remedy Ayelet Dilion Mashiah, CEO, Remedy Cell Ltd. http://www.bioworld.com/articles/730280 Mon, 13 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730280-spyres-spy-001-induces-better-outcomes-in-ulcerative-colitis Ulcerative colitis http://www.bioworld.com/articles/730262 Fri, 10 Apr 2026 09:00:00 -0400 https://www.bioworld.com/articles/730262-tipe2-silencing-attenuates-colitis Gastrointestinal system http://www.bioworld.com/articles/730258 Fri, 10 Apr 2026 09:00:00 -0400 https://www.bioworld.com/articles/730258-dxp-006-reduces-disease-severity-in-psoriasis-models Doctor holding illustration of cross section of skin http://www.bioworld.com/articles/730250 Thu, 09 Apr 2026 09:00:00 -0400 https://www.bioworld.com/articles/730250-leonabio-discovers-new-pannexin-1-inhibitors http://www.bioworld.com/articles/730244 Thu, 09 Apr 2026 09:00:00 -0400 https://www.bioworld.com/articles/730244-lcc-6-characterized-as-an-antifibrotic-and-copper-chelator-agent Photo of pipette with test tube http://www.bioworld.com/articles/730239 Thu, 09 Apr 2026 09:00:00 -0400 https://www.bioworld.com/articles/730239-milestone-under-cue-and-boehringer-ingelheim-collaboration Illustration of lymphocytes http://www.bioworld.com/articles/730201 Wed, 08 Apr 2026 09:00:00 -0400 https://www.bioworld.com/articles/730201-forward-therapeutics-patents-new-tnf-inhibitors http://www.bioworld.com/articles/730188 Wed, 08 Apr 2026 09:00:00 -0400 https://www.bioworld.com/articles/730188-fortitude-unveils-lead-program-for-axial-spondyloarthritis Spinal cord http://www.bioworld.com/articles/730205 Tue, 07 Apr 2026 11:00:00 -0400 https://www.bioworld.com/articles/730205-hematopoietic-stem-cell-research-points-to-leukemias-early-roots Cancer and blood cells http://www.bioworld.com/articles/730204 Tue, 07 Apr 2026 11:00:00 -0400 https://www.bioworld.com/articles/730204-five-drug-vipor-regimen-shows-promise-in-aggressive-blood-cancer PET scans showing before and after treatment with VIPOR Before (top) and after (bottom) treatment with VIPOR. Full-body and cross-sectional PET scans of a patient show large lymphoma tumors (circled in red) that have disappeared with treatment. Credit: Center for Cancer Research/National Cancer Institute http://www.bioworld.com/articles/730162 Thu, 02 Apr 2026 09:00:00 -0400 https://www.bioworld.com/articles/730162-hematopoietic-stem-cell-research-points-to-leukemias-early-roots Cancer and blood cells http://www.bioworld.com/articles/729980 Wed, 01 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/729980-five-drug-vipor-regimen-shows-promise-in-aggressive-blood-cancer PET scans showing before and after treatment with VIPOR Before (top) and after (bottom) treatment with VIPOR. Full-body and cross-sectional PET scans of a patient show large lymphoma tumors (circled in red) that have disappeared with treatment. Credit: Center for Cancer Research/National Cancer Institute http://www.bioworld.com/articles/729978 Wed, 01 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/729978-us-fda-warns-of-liver-injuries-8-deaths-associated-with-tavneos Liver over digital lens background http://www.bioworld.com/articles/730055 Wed, 01 Apr 2026 09:00:00 -0400 https://www.bioworld.com/articles/730055-hematopoietic-stem-cell-research-points-to-leukemias-early-roots Cancer and blood cells http://www.bioworld.com/articles/729964 Tue, 31 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729964-galapagos-enters-new-era-as-lakefront-after-reshaping-gilead-alliance Handshake icon engraved on metal hexagonal background http://www.bioworld.com/articles/730029 Mon, 30 Mar 2026 09:00:00 -0400 https://www.bioworld.com/articles/730029-sichuan-kelun-biotech-identifies-new-glucocorticoid-receptor-agonists http://www.bioworld.com/articles/730027 Mon, 30 Mar 2026 09:00:00 -0400 https://www.bioworld.com/articles/730027-ventus-therapeutics-patents-caspase-4-5-inhibitors http://www.bioworld.com/articles/730026 Mon, 30 Mar 2026 09:00:00 -0400 https://www.bioworld.com/articles/730026-rapt-therapeutics-synthesizes-new-tnf-modulators http://www.bioworld.com/articles/730013 Mon, 30 Mar 2026 09:00:00 -0400 https://www.bioworld.com/articles/730013-molecular-signatures-show-subtypes-in-neurodegenerative-diseases Illustration of a nerve cell with DNA double helix http://www.bioworld.com/articles/729930 Thu, 26 Mar 2026 09:00:00 -0400 https://www.bioworld.com/articles/729930-multibody-tev325-achieves-preclinical-milestone Illustration of a road with three destination markers http://www.bioworld.com/articles/729829 Tue, 24 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729829-gilead-pens-dual-purpose-2b-ouro-m-and-a-deal-with-galapagos Hands holding gears http://www.bioworld.com/articles/729823 Tue, 24 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729823-somatic-genomics-pioneer-quotient-signs-22b-ibd-deal-with-merck Gastrointestinal system with DNA, scientific background http://www.bioworld.com/articles/729869 Tue, 24 Mar 2026 09:00:00 -0400 https://www.bioworld.com/articles/729869-qilu-pharma-describes-new-vav1-degradation-inducers http://www.bioworld.com/articles/729865 Tue, 24 Mar 2026 09:00:00 -0400 https://www.bioworld.com/articles/729865-apex-biosciences-presents-new-phosphodiesterase-inhibitors